Paul Tudor Jones II's position in Encompass Health is currently worth $3.01M. That's 0.02% of their equity portfolio (858th largest holding). The first Encompass Health trade was made in Q1 2018. Since then Paul Tudor Jones II bought shares fifteen more times and sold shares on thirteen occasions. The investor's estimated purchase price is $3.41M, resulting in a loss of 12%.